Jejunal Atresia Associated with Cafergot® Ingestion During Pregnancy
Authors:
- 1 March 1983
- journal article
- case report
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 22 (3) , 226-228
Abstract
Fetal vascular accidents have been suggested as one cause for jejunal atresia due to in utero interruption of the superior mesenteric arterial supply to the intestines. Experimental studies support this hypothesis, and ergotamine has been shown to be a teratogen in experimental animals as a consequence of its vasoconstrictive action. We report the occurrence of intrauterine growth retar dation and jejunal atresia in an offspring of a woman who also experienced four spontaneous abortions. During each of six pregnancies, the mother had taken as many as eight Cafergot® tablets daily. We raise the hypothesis that Cafergot (1 mg ergotamine tartrate and 100 mg caffeine) might represent a vascular dis ruptive teratogenic agent during pregnancy. This hypothesis is supported by the clinical association of nonduodenal intestinal atresia with other defects that have a disruptive vascular etiology.Keywords
This publication has 15 references indexed in Scilit:
- Multiple intestinal atresias: Pathology and pathogenesisJournal of Pediatric Surgery, 1981
- Vascular pathogenesis of gastroschisisThe Journal of Pediatrics, 1981
- The vascular pathogenesis of gastroschisis: Intrauterine interruption of the omphalomesenteric arteryThe Journal of Pediatrics, 1981
- Monozygotic twinning and structural defectsThe Journal of Pediatrics, 1979
- The outcome of pregnancy in women suffering from migrainePostgraduate Medical Journal, 1978
- Vascular origin of Poland syndrome?European Journal of Pediatrics, 1978
- MIGRAINE DURING PREGNANCYObstetrical & Gynecological Survey, 1977
- Teratological experiments with ergotamine in mice, rats, and rabbitsTeratology, 1973
- Jejunal atresia with agenesis of the dorsal mesenteryThe American Journal of Surgery, 1966
- Jejunoileal atresia and stenosisJournal of Pediatric Surgery, 1966